Navigation

Press releases

The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.

Results 101-110 of 856

Pfizer's crizotinib not good value for NHS money, says NICE
NICE, the healthcare guidance body, has issued final guidance not recommending crizotinib (Xalkori, Pfizer) for previously treated anaplastic-lymphoma-kinase-positive advanced non-small-cell lung cancer.
September 25, 2013

NICE guidance recommends new test to guide breast cancer treatment decisions
NICE has recommended the use of the Oncotype DX test (Genomic Health) as an option to help clinicians decide whether to prescribe chemotherapy in people with early breast cancer.
September 25, 2013

NICE support for local authorities on improving children's social and emotional wellbeing
Support for local authorities to help children and young people to be confident, happy and reduce behavioural problems is the focus of a new NICE public health briefing published today.
September 25, 2013

NICE consults on proposed update to public health guidance for limiting harm caused by injecting drugs
Tens of thousands of people across England and Wales inject drugs like heroin and anabolic steroids each year, with others turning to Botox or other cosmetic injections like tanning agents. Now, the National Institute for Health and Care Excellence (NICE) is updating its guidance on how best to provide needle and syringe programmes.
September 24, 2013

Draft guidance from NICE asks for more information on multiple sclerosis treatment
The National Institute for Health and Care Excellence (NICE) is calling on Genzyme to provide more information on its multiple sclerosis drug, teriflunomide (also called Aubagio). In draft guidance published for consultation, NICE has requested a series of clarifications on the evidence submitted by the manufacturer.
September 18, 2013

Health and social care professionals encouraged to apply for NICE ambassador programmes
Health, public health and social care professionals across the UK are being encouraged to play a part in promoting high-quality, evidence-based care while boosting their own professional development by applying for Fellowships and Scholarships provided by NICE.
September 17, 2013

Don't suffer in silence, NICE updates treatment advice for the millions of women suffering from urinary incontinence
It is a problem that women are still embarrassed to speak about yet almost half of all women will experience some type of bladder dysfunction in their lifetimes. The National Institute for Health and Care Excellence (NICE) has issued an updated clinical guideline on the management of urinary incontinence (UI) in women in the hope that it helps to stop them suffering in silence. Treatment is available.
September 11, 2013

NICE seeks views to inform BNF accreditation decision
NICE has opened a consultation on its draft decision not to give NICE accreditation to the processes to produce the British National Formulary publications following a review by an independent advisory committee.
September 6, 2013

NICE gives green light to eye condition treatment in final draft guidance
NICE has published final draft guidance recommending ocriplasmin (Jetrea, ThromboGenics) as an option for treating some adults with the rare eye condition, vitreomacular traction.
August 30, 2013

'Breast cancer drug not cost-effective', says NICE
The National Institute for Health and Care Excellence (NICE) has found that everolimus, a breast cancer treatment, should not be recommended for use by the NHS because it is not a good use of limited NHS money.
August 28, 2013

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.